Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MM

Mark McDonnell — 36 Patents

Johnson & Johnson: 17 patents #567 of 7,810Top 8%
WBWistar Institute Of Anatomy And Biology: 7 patents #8 of 169Top 5%
BCBiohaven Pharmaceutical Holding Company: 5 patents #3 of 10Top 30%
RJRutgers, The State University Of New Jersey: 4 patents #174 of 1,498Top 15%
OLOligomerix: 3 patents #3 of 13Top 25%
OPOrtho-Mcneil Pharmaceutical: 2 patents #153 of 449Top 35%
Lansdale, PA: #20 of 839 inventorsTop 3%
Pennsylvania: #1,329 of 74,527 inventorsTop 2%
Overall (All Time): #92,222 of 4,157,543Top 3%
36 Patents All Time
Mark McDonnell has been granted 36 US patents while listed as an inventor at Johnson & Johnson. The first was granted in 2001 and the most recent in June 2025. Mark McDonnell ranks #92,222 of 4,157,543 US inventors in our database (top 2.2%). Patent records list Mark McDonnell in Lansdale, PA, US.

Patents per Year

Patents granted per year, 2001 to 2025Bar chart with a peak of 10 patents in 2013.peak 102001: 1 patents20012006: 1 patents2013: 10 patents20132014: 7 patents2017: 2 patents20172018: 2 patents2019: 2 patents20192020: 2 patents2021: 1 patents20212022: 4 patents2024: 2 patents20242025: 2 patents2025

Issued Patents All Time

Showing 1–25 of 36 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12331043 Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use Eliot J. Davidowitz, James G. Moe, Allen B. Reitz, Haiyan Bian, Charles Gluchowski +3 more 2025-06-17
12258314 EBNA1 inhibitors and their method of use Troy E. Messick, Garry Robert Smith, Allen B. Reitz, Paul Lieberman, Yan Zhang +1 more 2025-03-25
12172974 Prodrugs of riluzole and their method of use Garry Robert Smith, Allen B. Reitz, Suzie Chen, Matthew D. Vera, Benjamin E. Blass +3 more 2024-12-24
11912659 EBNA1 inhibitors and methods using same Troy E. Messick, Garry Robert Smith, Allen B. Reitz, Paul Lieberman, Yan Zhang +2 more 2024-02-27
11472776 Quinazolinones that inhibit the formation of tau oligomers and their method of use Eliot J. Davidowitz, James G. Moe, Allen B. Reitz, Haiyan Bian, Charles Gluchowski +3 more 2022-10-18
11440893 Prodrugs of riluzole and their method of use Garry Robert Smith, Allen B. Reitz, Suzie Chen, Matthew D. Vera, Benjamin E. Blass +3 more 2022-09-13
11306075 Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use Eliot J. Davidowitz, James G. Moe, Allen B. Reitz, Haiyan Bian, Charles Gluchowski +3 more 2022-04-19
11242317 EBNA1 inhibitors and their method of use Troy E. Messick, Garry Robert Smith, Allen B. Reitz, Paul Lieberman, Yan Zhang +1 more 2022-02-08
10981867 EBNA1 inhibitors and methods using same Troy E. Messick, Garry Robert Smith, Allen B. Reitz, Paul Lieberman, Yan Zhang +2 more 2021-04-20
10844026 Prodrugs of riluzole and their method of use Garry Robert Smith, Allen B. Reitz, Suzie Chen, Matthew D. Vera, Benjamin E. Blass +3 more 2020-11-24
10562870 Prodrugs of riluzole and their method of use Garry Robert Smith, Allen B. Reitz, Suzie Chen, Matthew D. Vera, Benjamin E. Blass +3 more 2020-02-18
10442763 EBNA1 inhibitors and methods using same Troy E. Messick, Garry Robert Smith, Allen B. Reitz, Paul Lieberman, Yan Zhang +2 more 2019-10-15
10421718 EBNA1 inhibitors and their method of use Troy E. Messick, Garry Robert Smith, Allen B. Reitz, Paul Lieberman, Yan Zhang +1 more 2019-09-24
10004722 Method for treating hepatic encephalopathy or a disease associated with free radical mediate stress and oxidative stress with novel functionalized 1,3-benzene diols Douglas E. Brenneman, William A. Kinney, Dean PETKANAS 2018-06-26
9856214 EBNA1 inhibitors and their method of use Troy E. Messick, Garry Robert Smith, Allen B. Reitz, Paul Lieberman, Yan Zhang +1 more 2018-01-02
9725427 Prodrugs of riluzole and their method of use Garry Robert Smith, Allen B. Reitz, Suzie Chen, Matthew D. Vera, Benjamin E. Blass +3 more 2017-08-08
9611213 Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy Douglas E. Brenneman, William A. Kinney, Dean PETKANAS 2017-04-04
8815839 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors Kristen Chevalier, Jose Clemente, Scott L. Dax, Chris Flores, Li Liu +7 more 2014-08-26 $45,866,000
8741887 Azetidinyl diamides as monoacylglycerol lipase inhibitors Haiyan Bian, Kristen Chevalier, Jose Clemente, Pete Connolly, Chris Flores +8 more 2014-06-03 $68,910,000
8697683 Azetidinyl diamides as monoacylglycerol lipase inhibitors Haiyan Bian, Kristen Chevalier, Jose Clemente, Peter J. Connolly, Christopher Flores +8 more 2014-04-15 $51,118,000
8697684 Azetidinyl diamides as monoacylglycerol lipase inhibitors Haiyan Bian, Kristen Chevalier, Jose Clemente, Pete Connolly, Chris Flores +8 more 2014-04-15 $51,118,000
8691805 Azetidinyl diamides as monoacylglycerol lipase inhibitors Haiyan Bian, Kristen Chevalier, Jose Clemente, Pete Connolly, Chris Flores +8 more 2014-04-08 $46,392,000
8637498 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors Peter J. Connolly, Mark J. Macielag, Bin Zhu 2014-01-28 $36,755,000
8623858 Azetidinyl diamides as monoacylglycerol lipase inhibitors Haiyan Bian, Kristen Chevalier, Jose Clemente, Pete Connolly, Chris Flores +8 more 2014-01-07 $46,576,000
8604017 Azetidinyl diamides as monoacylglycerol lipase inhibitors Haiyan Bian, Kristen Chevalier, Jose Clemente, Pete Connolly, Chris Flores +8 more 2013-12-10 $38,727,000